Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Research Grade Biosimilars

Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO) (HV612046)

Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)
Price(USD):
Spec:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HV612046
Description
Obrindatamab (HV612046) is a research-grade recombinant antibody targeting CD276. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivityHuman
ApplicationsELISA, Bioactivity: FCM, Functional assay, Research in vivo
Host speciesHuman
ClonalityMonoclonal
IsotypescFv with Domain Crossover, Kappa;Lambda
Tested applications WB
Target 4Ig-B7-H3, B7 homolog 3, B7-H3, B7H3, CD276, CD276 antigen, Costimulatory molecule, CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E
Endotoxin level < 10 EU/mg
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q5ZPR3 & P07766
Form Liquid
Storage buffer 0.01M PBS pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesBispecific, MGD009, RES281M1.1, hBRCA84D-hXR32-MP3M1.1, 2069959-72-2
BackgroundObrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer.
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
Images
  • Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Obrindatamab

  • Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)

    Bioactivity

    Detects CD276 in indirect ELISAs.

  • Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)

    Bioactivity

    Detects CD3E in indirect ELISAs.

  • Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)

    Bioactivity

    Detects CD276 in indirect ELISA.

  • Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)

    Bioactivity

    Detects Recombinant Human CD276 Protein, C-His (Cat No.: HV612011) in indirect ELISA.

  • Anti-Human CD276/B7-H3 & CD3 epsilon Bispecific Reference Antibody (Obrindatamab, RUO)

    Western blot

    Western blot analysis was performed using anti-CD276 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human CD276 (Catalog No: HV612011)
    Lane 2: negative control

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: [email protected]

Distributor list